Inhibition of thrombin-mediated factor V activation contributes to the anticoagulant activity of fibrinogen γ′

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 9, 2013, Pages 1669-1678

  Omarova, F ^a   Uitte De Willige, S ^b   Ariens R A S ^c   Rosing, J ^a   Bertina, R M ^d   Castoldi, E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Factor V; Fibrinogen; Fibrinogen gamma chain; Peptide; Thrombin

Indexed keywords

BLOOD CLOTTING FACTOR 5; FIBRINOGEN; FIBRINOGEN GAMMA; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; THROMBIN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ADULT; ANTICOAGULATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE FREE PLASMA;

FACTOR V; FIBRINOGEN; FIBRINOGEN-GAMMA CHAIN; PEPTIDE; THROMBIN;

AMINO ACID SEQUENCE; ANTICOAGULANTS; FACTOR V; FIBRINOGENS, ABNORMAL; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 84883789692     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12354     Document Type: Article

References (32)

1. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-904.
2. Chung DW, Davie EW. Gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 1984; 23: 4232-6.
3. Wolfenstein-Todel C, Mosesson MW. Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma'). Biochemistry 1981; 20: 6146-9.
4. Mosesson MW. Fibrinogen gamma chain functions. J Thromb Haemost 2003; 1: 231-8.
5. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem 2005; 70: 247-99.
6. Seegers WH, Nieft M, Loomis EC. Note on the adsorption of thrombin on fibrin. Science 1945; 101: 520-1.
7. Lane DA, Philippou H, Huntington JA. Directing thrombin. Blood 2005; 106: 2605-12.
8. Lovely RS, Moaddel M, Farrell DH. Fibrinogen gamma' chain binds thrombin exosite II. J Thromb Haemost 2003; 1: 124-31.
9. Meh DA, Siebenlist KR, Mosesson MW. Identification and characterization of the thrombin binding sites on fibrin. J Biol Chem 1996; 271: 23121-5.
10. Meh DA, Siebenlist KR, Brennan SO, Holyst T, Mosesson MW. The amino acid sequence in fibrin responsible for high affinity thrombin binding. Thromb Haemost 2001; 85: 470-4.
11. Lovely RS, Boshkov LK, Marzec UM, Hanson SR, Farrell DH. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway. Br J Haematol 2007; 139: 494-503.
12. Lovely RS, Rein CM, White TC, Jouihan SA, Boshkov LK, Bakke AC, McCarty OJ, Farrell DH. gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation. Thromb Haemost 2008; 100: 837-46.
13. Lancellotti S, Rutella S, De Filippis V, Pozzi N, Rocca B, De Cristofaro R. Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors. J Biol Chem 2008; 283: 30193-204.
14. Kane WH, Davie EW. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 1988; 71: 539-55.
15. Segers K, Dahlbäck B, Bock PE, Tans G, Rosing J, Nicolaes GA. The role of thrombin exosites I and II in the activation of human coagulation factor V. J Biol Chem 2007; 282: 33915-24.
16. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999; 107: 204-6.
17. Dupuy E, Soria C, Molho P, Zini JM, Rosenstingl S, Laurian C, Bruneval P, Tobelem G. Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin. Thromb Res 2001; 102: 211-9.
18. Uitte de Willige S, de Visser MC, Houwing-Duistermaat JJ, Rosendaal FR, Vos HL, Bertina RM. Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. Blood 2005; 106: 4176-83.
19. Grünbacher G, Weger W, Marx-Neuhold E, Pilger E, Köppel H, Wascher T, März W, Renner W. The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis. Thromb Res 2007; 121: 33-6.
20. Nowak-Göttl U, Weiler H, Hernandez I, Thedieck S, Seehafer T, Schulte T, Stoll M. Fibrinogen alpha and gamma genes and factor VLeiden in children with thromboembolism: results from 2 family-based association studies. Blood 2009; 114: 1947-53.
21. Mosesson MW, Cooley BC, Hernandez I, Diorio JP, Weiler H. Thrombosis risk modification in transgenic mice containing the human fibrinogen thrombin-binding gamma' chain sequence. J Thromb Haemost 2009; 7: 102-10.
22. Kumar R, Béguin S, Hemker HC. The influence of fibrinogen and fibrin on thrombin generation-evidence for feedback activation of the clotting system by clot bound thrombin. Thromb Haemost 1994; 72: 713-21.
23. Fredenburgh JC, Stafford AR, Leslie BA, Weitz JI. Bivalent binding to gammaA/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex. J Biol Chem 2008; 283: 2470-7.
24. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Béguin S. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002; 32: 249-53.
25. Castoldi E, Rosing J. Thrombin generation tests. Thromb Res 2011; 127(Suppl. 3): S21-5.
26. Hoekema L, Castoldi E, Tans G, Girelli D, Gemmati D, Bernardi F, Rosing J. Functional properties of factor V and factor Va encoded by the R2-gene. Thromb Haemost 2001; 85: 75-81.
27. Mosesson MW, Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb Haemost 2003; 89: 9-12.
28. de Bosch NB, Mosesson MW, Ruiz-Sáez A, Echenagucia M, Rodriguez-Lemoin A. Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I). Thromb Haemost 2002; 88: 253-8.
29. Farrell DH, Mulvihill ER, Huang SM, Chung DW, Davie EW. Recombinant human fibrinogen and sulfation of the gamma' chain. Biochemistry 1991; 30: 9414-20.
30. Alexander KS, Fried MG, Farrell DH. Role of electrostatic interactions in binding of thrombin to the fibrinogen γ' chain. Biochemistry 2012; 51: 3445-50.
31. Petrera NS, Stafford AR, Leslie BA, Kretz CA, Fredenburgh JC, Weitz JI. Long range communication between exosites 1 and 2 modulates thrombin function. J Biol Chem 2009; 284: 25620-9.
32. Pospisil CH, Stafford AR, Fredenburgh JC, Weitz JI. Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin. J Biol Chem 2003; 278: 21584-91.